NCT01542060View on ClinicalTrials.gov

Efficacy and Safety of Biphasic Insulin Aspart 30 for the Treatment of Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL

Enrollment

298

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2004

Study Completion Date

December 31, 2004

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

Administered via an insulin injection device. Dosages varied according to individual patients' medical requirement as determined by their attending clinician

Trial Locations (1)

11844

Amman